Acadia Pharmaceuticals Inc. (ACAD) stock analysis and AI prediction
The company facts of Acadia Pharmaceuticals Inc., with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About Acadia Pharmaceuticals Inc.
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on turning scientific promise into making a difference for underserved neurological and rare disease communities around the world. It has two franchises in neurological and rare diseases. Its neurological disease franchise is anchored by the commercial product NUPLAZID (pimavanserin), which is the first and only drug approved by the U.S. FDA for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis (PDP). Its rare disease is anchored by the commercial product DAYBUE, which is the first and only drug approved for the treatment of Rett syndrome. Its clinical-stage development efforts are focused on Alzheimer's disease psychosis, Lewy Body Dementia psychosis, and multiple other programs.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $3.1 billion
- Size
- Mid cap
- Employees
- 798
- Headquarters
- SAN DIEGO, CA
- Listed since
- May 27, 2004
- Website
- acadia.com
More Healthcare stocks
Other mid cap stocks
Keep going
ACAD questions
What is the AI prediction for ACAD stock?
Each market day our model rates Acadia Pharmaceuticals Inc. (ACAD) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the ACAD prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for ACAD?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see ACAD options?
The ACAD options page opens its calls and puts, with price, volume, implied volatility and the Greeks.